showed a trendP = .058
On meta-regression, anti-CD20 therapy was associated with lower response rates ( P < .001) and anti-tumor necrosis factor therapy also showed a trend toward lower response rates ( P = .058).
On meta-regression, anti-CD20 therapy was associated with lower response rates ( P < .001) and anti-tumor necrosis factor therapy also showed a trend toward lower response rates ( P = .058).